Pueraria (Pueraria mirifica) — Hermetica Encyclopedia
Herbs (Global Traditional) · Traditional Chinese Medicine

Pueraria (Pueraria mirifica)

Provisional Moderate Scorebotanical

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Pueraria mirifica is a Thai medicinal plant containing phytoestrogens including miroestrol and deoxymiroestrol that bind to estrogen receptors. It primarily supports menopausal symptoms by providing estrogenic activity through selective estrogen receptor modulation.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryHerbs (Global Traditional)
GroupTraditional Chinese Medicine
Public Score StatusProvisional Moderate
Primary KeywordPueraria mirifica benefits
Pueraria close-up macro showing natural texture and detail — rich in phytoestrogenic, antioxidant, anti-inflammatory
Pueraria (Pueraria mirifica) — botanical close-up

Origin & History

Pueraria growing in Southeast Asia — natural habitat
Natural habitat

Pueraria mirifica is a tropical herb native to Thailand and Southeast Asia, belonging to the legume family (Fabaceae), traditionally sourced from the plant's tuberous roots. The active compounds are extracted via solvent extraction or processed into capsules as phytoestrogen-rich powders or standardized extracts containing miroestrol and deoxymiroestrol.

In Thai traditional medicine, Pueraria mirifica (known as Kwao Keur Kao) has been used for centuries for rejuvenation and alleviating menopausal symptoms. Historical use in Southeast Asian herbal systems focused on treating estrogen deficiency-related issues like vaginal atrophy.Traditional Medicine

Research Narrative (Provisional)

A randomized, double-blind, placebo-controlled trial (n=71 postmenopausal women) tested 20-50mg daily for 24 weeks, showing improved vaginal health markers without significant adverse effects (PMID: 17415017). A systematic review of 8 studies (n=309) found ~50% reduction in climacteric scores but noted methodological flaws and lack of standardization (PMID: 29409850). Small open-label studies showed climacteric score reductions from 44.1 to 11.1 over 6 months (PMID: 17710964).

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Pueraria mirifica is a tuberous root plant whose nutritional composition is secondary in importance to its concentrated phytoestrogenic bioactive compounds. Macronutrient breakdown of the dried root powder is approximately: carbohydrates 60-70% (primarily starch and dietary fiber), protein 8-12%, fat 1-3%, moisture 8-10%. Dietary fiber content is approximately 15-20g per 100g dried root. The defining bioactive constituents are phytoestrogens, particularly the unique chromene-type miroestrol and deoxymiroestrol (estimated 0.01-0.1% dry weight), which exhibit estrogenic potency reportedly 3,000-fold greater than soy isoflavones on a molar basis. Isoflavones present include puerarin (daidzein-8-C-glucoside, ~0.5-2.0% dry weight), daidzein (~0.1-0.5%), genistein (trace amounts), and kwakhurin. Coumestans include coumestrol (0.05-0.2%). Additional phytochemicals include spinasterol, campesterol, stigmasterol (plant sterols, ~0.1-0.3%), and mirificin (a pterocarpan glycoside). Micronutrient data is limited but the root contains moderate potassium (~400-600mg/100g dry weight), calcium (~80-120mg/100g), magnesium (~30-50mg/100g), and trace iron and zinc. Bioavailability notes: miroestrol and deoxymiroestrol undergo hepatic first-pass metabolism; isoflavone bioavailability is gut-microbiome dependent with equol-producer status significantly affecting estrogenic activity; standardized extracts typically normalized to 20-50mg isoflavones per dose used in clinical studies.

Reported Mechanism (Provisional)

Mechanism of Action

Pueraria mirifica's bioactive compounds miroestrol and deoxymiroestrol act as selective estrogen receptor modulators (SERMs), binding to both ERα and ERβ receptors. These phytoestrogens mimic endogenous estradiol, activating estrogen-responsive pathways in target tissues including vaginal epithelium. The isoflavones genistein and daidzein provide additional weak estrogenic activity through competitive receptor binding.

Clinical Narrative (Provisional)

A randomized controlled trial (n=71) demonstrated that Pueraria mirifica significantly reduced vaginal dryness and dyspareunia in postmenopausal women. The study showed improvement in vaginal maturation index, with superficial cells increasing from 11% to 24% while parabasal cells decreased from 46% to 11%. Evidence for climacteric symptom relief exists but requires larger clinical trials for definitive conclusions. Current research is limited by small sample sizes and short study durations.

Also Known As

Pueraria mirificaKwao Keur KaoWhite Kwao KruaThai KudzuMiracle RootButea superba (related species)PM Extract

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.